Detalhe da pesquisa
1.
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Blood
; 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38662991
2.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Lancet
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38705160
3.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
Blood
; 137(23): 3251-3258, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33513604
4.
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Eur J Haematol
; 111(2): 220-228, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37094812
5.
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Br J Haematol
; 198(3): 482-491, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35362552
6.
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
Int J Cancer
; 148(1): 150-160, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32638373
7.
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
N Engl J Med
; 378(13): 1211-1223, 2018 03 29.
Artigo
Inglês
| MEDLINE | ID: mdl-29590547
8.
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Ann Hematol
; 100(8): 2043-2050, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33973053
9.
Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.
Eur J Haematol
; 107(5): 543-552, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34288114
10.
Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.
Oncologist
; 25(5): e816-e832, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32219909
11.
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis.
Blood
; 142(16): 1399-1403, 2023 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37523714
12.
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Int J Cancer
; 144(11): 2695-2706, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30447004
13.
Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).
Strahlenther Onkol
; 195(6): 544-557, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30859254
14.
High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.
J Immunol
; 198(10): 3765-3774, 2017 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28416603
15.
ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.
Bioinformatics
; 33(3): 435-437, 2017 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28172348
16.
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Blood
; 127(8): 1007-16, 2016 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-26675346
17.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27313086
18.
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
Blood
; 126(5): 604-11, 2015 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-26022239
19.
Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.
Am J Pathol
; 185(6): 1740-8, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25843681
20.
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Lancet Oncol
; 16(9): 1111-1122, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26256760